QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 发表日期：2018     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Structural Basis of the Proton Sensitivity of Human GluN1-GluN2A NMDA Receptors 期刊论文 Cell reports, 2018, 卷号: 25, 期号: 13, 页码: 3582-3590.e4 作者:  Zhang, Jin-Bao;  Chang, Shenghai;  Xu, Pan;  Miao, Miao;  Wu, Hangjun 收藏  |  浏览/下载：118/0  |  提交时间：2019/01/08 Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Fruquintinib After Two Prior Chemotherapy Regimens in Chinese Patients With Advanced Nonsquamous NonSmall-Cell Lung Cancer 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2018, 卷号: 36, 期号: 12 作者:  Yang, Jin-ji;  Zhou, Jianying;  Wang, Jie;  An, Tongtong;  Yang, Lei 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Fruquintinib After Two Prior Chemotherapy Regimens in Chinese Patients With Advanced Nonsquamous NonSmall-Cell Lung Cancer 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2018, 卷号: 36, 期号: 12 作者:  Lu, Shun;  Chang, Jianhua;  Liu, Xiaoqing;  Shi, Jianhua;  Lu, You 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05 Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial 期刊论文 2018, 卷号: 6, 期号: 9, 页码: 681-690 作者:  Wang, Zhijie;  Cheng, Ying;  An, Tongtong;  Gao, Hongjun;  Wang, Kai 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03